Alvarez J, Boklund A, Dippel S, Dorea F, Figuerola J, Herskin M
EFSA J. 2025; 23(1):e9191.
PMID: 39882189
PMC: 11775931.
DOI: 10.2903/j.efsa.2025.9191.
Feoktistova S, Ivanova A, Degtyarev E, Smirnova D, Volchkov P, Deviatkin A
Viruses. 2024; 16(11).
PMID: 39599771
PMC: 11598867.
DOI: 10.3390/v16111656.
Page C, Tompkins S
Viruses. 2024; 16(9).
PMID: 39339833
PMC: 11435980.
DOI: 10.3390/v16091356.
Zhang Z, Zhang Z, Wang C, Zhai X, Wang W, Chen X
BMC Vet Res. 2024; 20(1):203.
PMID: 38755641
PMC: 11097555.
DOI: 10.1186/s12917-024-04040-9.
Ran H, Zhou X, Liu W, Gao G
Infect Dis Immun. 2024; 1(2):103-107.
PMID: 38630078
PMC: 8291037.
DOI: 10.1097/ID9.0000000000000011.
Insights from Avian Influenza: A Review of Its Multifaceted Nature and Future Pandemic Preparedness.
He J, Kam Y
Viruses. 2024; 16(3).
PMID: 38543823
PMC: 10975894.
DOI: 10.3390/v16030458.
H7N6 highly pathogenic avian influenza in Mozambique, 2023.
Monjane I, Djedje H, Tamele E, Nhabomba V, Tivane A, Massicame Z
Emerg Microbes Infect. 2024; 13(1):2321993.
PMID: 38422451
PMC: 10906114.
DOI: 10.1080/22221751.2024.2321993.
Characterization of a reassortant H11N9 subtype avian influenza virus isolated from spot-billed duck in China.
Wang B, Huang Y, Hu B, Zhang H, Han S, Yang Z
Virus Genes. 2023; 59(4):604-612.
PMID: 37266848
PMC: 10235845.
DOI: 10.1007/s11262-023-02009-8.
Comparative pathogenic potential of avian influenza H7N3 viruses isolated from wild birds in Egypt and their sensitivity to commercial antiviral drugs.
Kayed A, Kutkat O, Kandeil A, Moatasim Y, El Taweel A, Sayes M
Arch Virol. 2023; 168(3):82.
PMID: 36757481
PMC: 9909137.
DOI: 10.1007/s00705-022-05646-w.
Genome sequence analysis of H7N3 subtype avian influenza virus originated from wild birds and its potential infectivity in mice.
Yin X, Wu T, Peng C, Li J, Liu S, Hou G
Virus Genes. 2023; 59(2):240-243.
PMID: 36735176
DOI: 10.1007/s11262-023-01968-2.
Alarming situation of emerging H5 and H7 avian influenza and effective control strategies.
Shi J, Zeng X, Cui P, Yan C, Chen H
Emerg Microbes Infect. 2022; 12(1):2155072.
PMID: 36458831
PMC: 9754034.
DOI: 10.1080/22221751.2022.2155072.
Genetic Characterization and Pathogenicity of H7N7 and H7N9 Avian Influenza Viruses Isolated from South Korea.
Na E, Kim Y, Kim Y, Park J, Oem J
Viruses. 2021; 13(10).
PMID: 34696486
PMC: 8540337.
DOI: 10.3390/v13102057.
Multiple basic amino acids in the cleavage site of H7N9 hemagglutinin contribute to high virulence in mice.
Song W, Huang X, Guan W, Chen P, Wang P, Zheng M
J Thorac Dis. 2021; 13(8):4650-4660.
PMID: 34527306
PMC: 8411188.
DOI: 10.21037/jtd-21-226.
Too young to die? How aging affects cellular innate immune responses to influenza virus and disease severity.
Harpur C, Le Page M, Tate M
Virulence. 2021; 12(1):1629-1646.
PMID: 34152253
PMC: 8218692.
DOI: 10.1080/21505594.2021.1939608.
The paradoxical problem with COVID-19 ocular infection: Moderate clinical manifestation and potential infection risk.
Shen J, Wu J, Yang Y, Wang P, Luo T, Guo Y
Comput Struct Biotechnol J. 2021; 19:1063-1071.
PMID: 33613871
PMC: 7881169.
DOI: 10.1016/j.csbj.2021.01.039.
Development and evaluation of a monoclonal antibody-based competitive ELISA for the detection of antibodies against H7 avian influenza virus.
Li Y, Ye H, Liu M, Song S, Chen J, Cheng W
BMC Vet Res. 2021; 17(1):64.
PMID: 33531001
PMC: 7852141.
DOI: 10.1186/s12917-021-02772-6.
Characterization of the low-pathogenic H7N7 avian influenza virus in Shanghai, China.
Tang W, Li X, Tang L, Wang T, He G
Poult Sci. 2021; 100(2):565-574.
PMID: 33518109
PMC: 7858150.
DOI: 10.1016/j.psj.2020.11.018.
Analysis of the Codon Usage Pattern of HA and NA Genes of H7N9 Influenza A Virus.
Sun J, Zhao W, Wang R, Zhang W, Li G, Lu M
Int J Mol Sci. 2020; 21(19).
PMID: 32992529
PMC: 7583936.
DOI: 10.3390/ijms21197129.
SARS-CoV-2 on the ocular surface: is it truly a novel transmission route?.
Chen X, Yu H, Mei T, Chen B, Chen L, Li S
Br J Ophthalmol. 2020; 105(9):1190-1195.
PMID: 32788324
PMC: 8380887.
DOI: 10.1136/bjophthalmol-2020-316263.
Certainty of success: three critical parameters in coronavirus vaccine development.
Kaslow D
NPJ Vaccines. 2020; 5(1):42.
PMID: 32509338
PMC: 7248068.
DOI: 10.1038/s41541-020-0193-6.